Humana Inc
$40.68B- Market cap
- $48.21B
- Debt
- +$12.37B
- Cash
- −$19.90B
Capital structure 80% equity / 20% debt · EV / Revenue 0.31x · EV / EBITDA 11.87x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $48.21B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2026 · Mkt cap
Decision snapshot: HUM stock price at premium vs WLY $401.54 current versus $113.99 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at WLY's multiple
Implied fair value · at HUM's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple discount
Premium justified
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: HUM FY 2025 (ended Dec 31, 2025) · WLY FY 2026 (ended Apr 30, 2026). Fiscal years are not aligned.
Trendline
Ten fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 80% equity / 20% debt · EV / Revenue 0.31x · EV / EBITDA 11.87x
Capital structure 81% equity / 19% debt · EV / Revenue 2.12x · EV / EBITDA 7.95x
HUM carries the larger enterprise value at $40.68B against $3.55B; HUM trades on the lower EV / Revenue multiple (0.31x vs 2.12x); WLY on the lower EV / EBITDA (7.95x vs 11.87x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
HUMANA INC · implied price per share
Bear
$260.99
Base
$299.78
Bull
$352.11
JOHN WILEY & SONS, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.70x
0.82x
Net debt / EBITDA
Leverage against operating earnings
-2.20x
1.39x
Cash and equivalents
Liquid reserves on the balance sheet
$19.90B
$75.62M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
UNITEDHEALTH GROUP INC
HUM vs UNH
Elevance Health, Inc.
HUM vs ELV
CVS HEALTH Corp
HUM vs CVS
Cigna Group
HUM vs CI
CENTENE CORP
HUM vs CNC
Oscar Health, Inc.
HUM vs OSCR
NEWS CORP
HUM vs NWSA
NEW YORK TIMES CO
HUM vs NYT
Barnes & Noble Education, Inc.
HUM vs BNED
RELX PLC
HUM vs RELX
SCHOLASTIC CORP
HUM vs SCHL
$12.37B
$695.90M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.